Investigates gut microbiota metabolites influencing lung inflammation in a murine model, suggesting therapeutic targets.
This study investigates how gut microbiota-derived metabolites modulate pulmonary immune responses to Aspergillus fumigatus infection. We employed a multi-omics approach to characterize the functional impact of antibiotic-altered gut microbial communities on lung inflammation in a murine model of intranasal fungal challenge. Fecal 16S rRNA gene sequencing was performed to profile bacterial community composition across distinct antibiotic regimens, while targeted metabolomics of fecal samples and untargeted metabolomics of serum were conducted to capture systemic metabolic shifts, with a focus on tryptophan-indole derivatives.
No takes yet. Share an insight, caveat, or question.
王垲智(Kaizhi Wang) (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: